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To catheterize the CS, a sheath isused in first intention in 81%. CS angi-
ography is performed in 90%, with an inflated balloon in 59%.
In case of atrial fibrillation withCHA2DS2-vasc<2, 38% implant without
VKA interruption, 57% stop VKA without substitution, and unfractionned
heparin (UH) or low weight heparin (LWH) substitution is chosen in 5%, vs
respectively 69% and 11% and 19% if CHA2DS2-vasc >4. 
Conclusion: Most of implantations are performed under local anesthesia. Left
sided is prefered, especially in case of CRT-D implantation. Most physicians com-
bine the venous accesses, start with the RV septal lead, and perform a CS angio-
gram via an inflated balloon. In AF patient, VKA interruption is preferred in low
risk patients but not in high risk ones. Few implanters choose VKA substitution.
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Increased rates of structural abnormalities have been reported in the Riata
family of implantable cardioverter-defibrillator (ICD) leads. The reliability of
defibrillation leads with insulation damage, or abraded cables that are not
immediate cause of failure is unknown. The incidence of these defects can be
underestimated due to the absence of abnormal electrical parameters detected
by regular ICD interrogation. Little is known about the time lag for emergence
of functional abnormalities in such leads.
Methods: Forty eight patients who received small-caliber leads of the
Riata family (models 1570, 1572, 1580, 1582, 7000, 7002) in our institution
between May 2002 and March 2008 were systematically called for an addi-
tional visit including face-profile thoracic fluoroscopy to ascertain integrity of
the leads followed by routinely repeated fluoroscopies at every six-month
visits. We assessed the prevalence of insulation defects with externalized
cables and their relation with adverse events requiring lead revision. We tried
to evaluate the time lag for emergence of their electrical dysfunction.
Results: Thirty five patients, mean age=64±10 years, with at least 7-month
completed fluoroscopy follow-up were included in analysis. After 55-month
mean follow-up, 57% of patients completed 2 or more spaced fluoroscopies.
Externalized conductors were identified in 7 (20%) patients after a 48-months
(12-114) mean delay and in 4 (11%) cases the images were classified as border-
line. Three of 7 patients with insulation damage required lead replacement for the
reason of clinical adverse events. In two other patients an increase of abrasion
was observed on repeated fluoroscopy without changes in electrical parameters.
Conclusion: Insulation damage with externalized conductors was identi-
fied in 20% of patients implanted with Riata leads. Routine fluoroscopic
screening allowed earlier detection of these defects and may be useful for their
closer monitoring and better management.
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Introduction: Both type 1 Myotonic Dystrophy (Steinert disease) and Bru-
gada syndrome may be complicated by conduction disturbances and sudden
death. ST elevation in the right precordial leads is the hallmark of Brugada
syndrome but may be seen in some myopathies. Mutations in DMPK gene in
Steinert pts may lead to cytosolic accumulation of muted toxic RNA or altered
alternate splicing of some RNA potentially causing sodium channel dysfunc-
tions. The prevalence of Brugada ECG pattern in Steinert disease is unknown.
Methods: we perform ajmaline challenge test (1 mg/kg over 5 min) during
electrophysiological (EP) testing in a population of 44 Steinert disease pts
(27 men, 41±15 years old) without ST elevation at baseline. Left ventricular
EF was normal in each case. The presence of type 1 ST elevation (> 2 mm J
elevation with coved ST and negative T wave) after ajmaline challenge was
correlated to clinical, ECG and electrophysiological variables.
Results: 8 pts (18%) present type 1 ST elevation in the right precordial
leads after ajmaline infusion. Brugada pattern was more often seen in men:
7/27 (26%) vs 1/17 (6%) (p=0.09). Patients with negative ajmaline test pre-
sented more often with fascicular block: 13/35 (27%) versus none (p=0.03).
Brugada pattern was not correlated to age, symptoms, PR interval, QRS,
QT or QTc durations, HV interval (at baseline or after ajmaline), presence of
bundle branch block, of late potentials at SA-ECG or inducibility of ventric-
ular arrhythmias at EP study.
Nine pts were implanted with a pace maker and four with an ICD. Signi-
ficant or symptomatic bradycardia did not happen in any non implanted pts,
while only one pt presented with malignant ventricular arrhythmias during the
6.3±2.6 years follow-up (ventricular fibrillation with hypokaliemia in an ajma-
line negative pt).
Conclusion: Brugada ECG pattern can be elicited by class 1 drug in 18%
of Steinert disease pts and especially in men. Presence of type 1 ST elevation
under class 1 drug in Steinert disease do not seem to have some significant
clinical or ECG correlations.
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Purpose: Surgical epicardial AICD implantation has been quite abandoned
since developpement of endocardial leads and decrease in AICD size. Epicar-
dial patches did not improve since 30 years, are rigid and need to be sewed to
the epicard which favors bleeding. In some rare cases, epicardial AICD implan-
tation remains indicated. Therefore we tested a new simple implant technique
in 5 patients undergoing open chest surgery trough a median sternotomy.
Methods: In 3 cases surgery was performed for percutaneous infected lead
extraction failure. The two other patients required surgical operation and
AICD implant (one for mitral valve regurgitation, one for tricuspid repair). A
screw-in bipolar pace/sense lead (St Jude MyodexTM 1084T) was placed on
the right ventricular free wall and two defibrillation leads (Medtronic Trans-
vene®6937) were respectively sewed on the pulmonary artery trunk and on
the diaphragmatic wall of the right ventricle and then connected to an AICD
(Biotronik Lumax 540) placed in an abdominal pocket.
Results: Best defibrillation configuration (31 J tested) was obtained with a
shock delivered between the two coils (AICD passive), from the inferior one
to the superior one. There were no major cardiovascular complications.
Clinical and telemonitoring follow up (mean 10 months) showed stable ven-
tricular stimulation and detection thresholds as well as lead and coil impe-
dances. No arrhythmias occurred.
Conclusions: Epicardial AICD implantation is feasible in a simple way.
Long term follow up is needed to confirm post operative results.
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